ReviewFrontiers in cardiovascular medicine2026
Effects of standing Baduanjin exercise on cardiac function and quality of life in patients with chronic heart failure: a systematic review and meta-analysis.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic heart failure (CHF) is characterized by progressive cardiac dysfunction and impaired quality of life (QoL), which contribute to poor prognosis and frequent hospital readmissions. Standing Baduanjin exercise (SBE), a standing-form traditional Chinese mind-body exercise that integrates gentle movements, breathing control, and mental focus, has been increasingly applied in cardiac rehabilitation in China. However, although a growing number of randomized controlled trials (RCTs) have investigated SBE, a comprehensive synthesis of high-quality evidence regarding its effects on cardiac function and QoL in patients with CHF remains limited. Purpose: To evaluate the effects of SBE on cardiac function and QoL in patients with CHF. Methods: Following PRISMA and Cochrane guidelines, eight databases were searched for RCTs published up to October 2025. Study quality was assessed using the Cochrane Risk of Bias tool and modified Jadad scale. Meta-analysis was performed using Stata version 18.0, with subgroup analyses conducted based on intervention duration. Sensitivity analysis was performed by sequentially excluding individual studies, and publication bias was evaluated using Egger's test. Results: Fifty RCTs involving 3,964 participants were included. Compared with conventional pharmacotherapy (CPT) alone, SBE significantly improved left ventricular ejection fraction (LVEF: SMD = 0.98, 95% CI: 0.80-1.15, Conclusion: Current evidence suggests that SBE is an effective, safe, and practical adjunctive intervention for CHF, capable of improving both cardiac function and QoL. Further high-quality multicenter RCTs are warranted to confirm these findings and explore long-term outcomes. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251175888, identifier CRD420251175888.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.